MSOS Weekly Review | Jul 27–31, 2026

Despite limited headline reaction, MSOS held above recent support while participation remained narrow.

MSOS was little changed during the review week.

Participation remained mixed, with breadth and trading activity not yet confirming a broader advance.

Policy developments remained active during the review period, although market reaction stayed measured.

Key Takeaways

• MSOS was essentially flat over Jul 27, 2026 – Jul 31, 2026.
• Participation remained mixed, with breadth and trading activity not yet confirming a broader advance.
• Policy developments remained active during the review period, although market reaction stayed measured.

MSOS traded in a narrow band over Jul 27, 2026 – Jul 31, 2026, suggesting investors remain in wait-and-see mode ahead of clearer policy or liquidity confirmation.

Participation was balanced, with advancers and decliners roughly matched. Liquidity was subdued, with average volume slightly lower, spreads relatively contained, and volatility moderate.

Federal cannabis scheduling developments remained in focus last week as the DEA continued advancing procedural steps in the Schedule III review process, with limited near-term earnings implications for major U.S. operators.

The market response remained muted, suggesting investors are still discounting procedural DEA steps until a clearer final-rule timeline emerges.

State-level developments in Texas and Illinois remained active, though most appear unlikely to materially change near-term earnings expectations for major U.S. operators.

MSOS remains well above its three-month low but below the upper end of its three-month range. Relative strength remained concentrated in MSOS and TLRY, while SNDL continued to lag. Leadership remains narrow rather than broadly constructive.

Overall posture: Neutral to mildly constructive

Next week’s tape will likely be shaped by whether policy headlines, breadth, and liquidity begin to confirm the recent stabilization.

• Monitor whether MSOS can sustain closes above key moving averages after the latest weekly gain.
• Watch whether advancers begin to outnumber decliners by a wider margin across the tracked universe.
• Track whether dollar volume expands alongside price gains or fades into thinner trading conditions.
• Follow developments from the DEA hearing and any scheduling, banking, or tax-related federal updates.
• Track operator financing, guidance revisions, earnings updates, and exchange-related announcements for changes in relative strength leadership.
• DEA scheduling developments — whether policy momentum becomes investable confirmation rather than procedural background